J. Anthony Ware sold $1.8M of TRAX
director at First Tracks Biotherapeutics, Inc.. 39,265 shares at an average of $44.78, traded Sep 2, 2026, filed Sep 4, 2026.
Score components
- +15RoleDirector
- +25Trade size$1.8M at market
- +20Share of holdings soldSold 71% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001715429-26-000007, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | MOption exercise Common Stock | +39,265 | $5.74 | $225k | 54,925 | 38 d ago |
| Sep 2, 2026 | SOpen-market sale Common Stock | -39,265 | $44.78 | $1.8M | 15,660 | 38 d ago |
| Sep 2, 2026 | MOption exercise Stock Option (right to buy)derivative | -28,571 | $0.00 | $0 | 0 | 38 d ago |
| Sep 2, 2026 | MOption exercise Stock Option (right to buy)derivative | -10,694 | $0.00 | $0 | 0 | 38 d ago |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.